öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÎºÐ¡ÓÂ
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º723

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º201»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÖÐÒ½Ò©·ÀÖÎÌÇÄò²¡¼°Æä²¢·¢Ö¢¡¢·ÊÅÖÖ¢µÈ£¬ÖÐÒ©µ¥·Ö×ÓÒ©Àí£¬ÖÐÒ©
Ñо¿ÁìÓò£º ÖÐÒ½Ò©·ÀÖÎÌÇÄò²¡¼°Æä²¢·¢Ö¢¡¢·ÊÅÖÖ¢µÈ£¬ÖÐÒ©µ¥·Ö×ÓÒ©Àí£¬ÖÐÒ© [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÊö
1969Äê4Ô³öÉú£¬ºþÄÏÓÀÖÝÈË£¬ºº×壬Öй²²úµ³Ô±£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦¼°²©Ê¿ºóºÏ×÷µ¼Ê¦¡£
Ö÷ÒªÈÙÓþ
ÄÏÒ©×ÊÔ´¿É³ÖÐø¿ª·¢ÀûÓõÄϵÁÐÑо¿£¬¹ú¼Ò½ÌÓý²¿¿Æ¼¼½ø²½Ò»µÈ½±£¬2012Äê¡£
ʯõú¿¹ÌÇÄò²¡ÐÔ°×ÄÚÕÏ×éºÏ°Ðµ°°×¼°×éºÏÓÐЧ³É·ÖµÄɸѡÑо¿£¬¹ãÖÝÖÐÒ½Ò©´óѧ×ÔÈ»¿ÆÒ»µÈ½±£¬2010Äê
ÌúƤʯõú²î¼õcDNAÎÄ¿âµÄ¹¹½¨¼°¼ø¶¨£¬µÚ¾Å½ìÈ«¹úÌôÕ½±­±ÈÈüÈýµÈ½±£¬Ö¸µ¼½Ìʦ£¬2005Äê¡£
¹ã¶«Ê¡¡°Ç§°ÙÊ®¡±ÅàÑø¶ÔÏó£¬2006ÖÁ2010Äê
¹ãÖÝÖÐÒ½Ò©´óѧ²úѧÑÐÏȽø¸öÈË£¬2008Ä꣬2010Ä꣬2012Äê¡£
¹ãÖÝÖÐÒ½Ò©´óѧÓÅÐã¿Æ¼¼¹¤×÷Õߣ¬2011Äê¡£
ÐÂÄÏ·½ÓÅÐã½ÌʦÌáÃû½±£¬2006Ä꣬2008Äê¡£

¿ÆÑй¤×÷ :
¹¤×÷¾­Àú
1998Äê7ÔÂÖÁ2014Äê2ÔÂÔÚ¹ãÖÝÖÐÒ½Ò©´óѧ¹¤×÷¡£2009Äê11Ô½úÉýΪ½ÌÊÚ¡£
2014Äê3ÔÂÖÁ2015Äê3ÔÂÔÚÃÀ¹úËþ·òÖ¥´óѧ£¨TuftsUniersity£©·ÃÎʽÌÊÚ.
2015Äê3ÔÂÖÁ½ñÔÚ¹ãÖÝÖÐÒ½Ò©´óѧ¹¤×÷ÈνÌÊÚ¡£
ѧÊõ¼æÖ°
¹ã¶«Ê¡½âÆÊѧ»á³£ÎñÀíÊ¡£
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðͨѶÆÀÒéר¼Ò¡£
Áôѧ¹é¹úÈËÔ±/¹ã¶«Å·ÃÀͬѧ»áÀíÊ¡£
Journalofbiologicalchemistry¡¢JournalofEthnopharmacology¡¢CellBiologyInternational£¬PLoSOne¡¢BMCComplementaryandAlternativeMedicine¡¢EvidBasedComplementAlternatMedµÈ¹ú¼ÊÔÓÖ¾Éó¸åÈË¡£
¿ÆÑÐÏîÄ¿
[1]1/1/2013-12/31/2016£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬Ê¯õú¿¹ÌÇÄò²¡ÐÔ°×ÄÚÕÏ»îÐԳɷÖÓë°Ðµ°°×Ö®¼ä·Ö×Óʶ±ðÑо¿£¨**£©
[2]1/1/2012-1/31/2014£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬Ê¯õú·Ó¡¢¶¡ÏãËáÓëLEC±íÃæÊÜÌåʶ±ðÑо¿£¬£¨**£©
[3]1/1/2009-1/31/2011£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬ÐÂɸѡµÄʯõú¿¹ÌÇÄò²¡ÐÔ°×ÄÚÕÏÓÐЧ³É·Ö×÷ÓûúÖƵÄÑо¿£¨**£©
[4]10/1/2009-10/31/2013£¬¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬Ê¯õú·Ó(gigantol)¼°ÆäÑÜÉúÎïµÄºÏ³ÉºÍ¹¹Ð§¹ØϵÑо¿£¨S**1£©
[5]12/1/2006-1/31/2009£¬¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬Ê¯õúÌáÈ¡ÎÌÇÐÔ°×ÄÚÕÏ×éºÏ°Ðµ°°×¼°ÓÐЧ³É·ÖµÄɸÑ¡£¨**£©
[6]1/1/2012-1/31/2014£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬Ê¯õú·ÓµÄÈ«ºÏ³É¼°Æä»îÐԺͳÉÒ©ÐÔÆÀ¼ÛÑо¿£¨2011B**£©
[7]4/1/2017-5/1/2020£¬¹ã¶«Ê¡¸ßˮƽ´óѧ½¨ÉèÃæÉÏÏîÄ¿£¬Ê¯õú·Ó¡¢¶¡ÏãËáÓëAR¡¢iNOS»ùÒòת¼µ÷¿ØÔª¼þµÄ·Ö×Óʶ±ð¼°ÆäÏ໥×÷ÓÃÑо¿£¨A1-AFD018171Z11023£©
[8]1/1/2017-12/31/2019£¬¹ã¶«Ê¡¸ßˮƽ´óѧ½¨ÉèÃæÌØÉ«´´ÐÂÏîÄ¿£¬Ê¯õú¿¹ÌÇÄò²¡ÐÔ°×ÄÚÕÏ»îÐԳɷÖÓë°Ð±ê»ùÒòÏ໥×÷Óü°¶ÔÌÇÎÈ̬ʧºâµÄµ÷¿ØÑо¿£¨A1-AFD018171Z1310£©
[9]4/1/2009-1/31/2013£¬¹ã¶«Ê¡½ÌÓý²¿²úѧÑнáºÏÏîÄ¿£¬ÐÂÒ©¡°Ê¯õúµÎÑÛÒº¡±£¨ÖÐÒ©Ò»ÀࣩÁÙ´²Ç°³õ²½Ñо¿£¨2009B**£©
[10]4/1/2003-1/31/2015£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÖصãÏîÄ¿£¬ÌúƤʯõú¹æÄ£»¯Éú²úÌåϵ¡¢¸ßͨÁ¿¼ø¶¨¼°ÆäÖÊÁ¿¿ØÖÆÑо¿£¨**007£©
[11]1/1/2014-1/31/2016£¬¹ãÖÝÊпƼ¼¼Æ»®ÏîÄ¿£¬Ê¯õú¿¹ÌÇÐÔ°×ÄÚÕÏÓÐЧ³É·ÖÓëAR¡¢iNOSµ¥·Ö×Óʶ±ðÑо¿£¨2014J**£©
[12]12/1/2009-1/31/2012£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬ÌúƤʯõú±ê×¼»¯Éú²úÌåϵ¼°×ۺϲúÆ·¿ª·¢Ñо¿£¨**123£©
[13]12/1/2008-1/31/2010£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬ÌúƤʯõú×éÅà¿ì·±Ð¹¤ÒÕ¼°¸ßÃܶÈGAPÑо¿£¨**005£©
[14]9/1/2005-9/30/2007£¬¹ã¶«Ê¡ÎÀÉúÌüÏîÄ¿£¬Âã£Ä£Î£ÁµçתÒƣУԣȻùÒòÖÎÁÆSTZÓÕµ¼µÄDCСÊóµÄʵÑéÑо¿£¨105061£©
[15]1/1/2004-12/31/2005£¬¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾ÖÏîÄ¿£¬ÌúƤʯõú¶àÌǺϳÉ;¾­Ïà¹Ø¹¦ÄÜ»ùÒòµÄ¿Ë¡£¨303005£©
[16]1/1/2003-12/31/2004£¬¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾ÖÏîÄ¿£¬ÌúƤʯõúÒ©ÓÃÏà¹Ø¹¦ÄÜ»ùÒòµÄÑо¿£¨402003£©¡£


Ö÷ÒªÂÛÎÄ
[1]LiX,LiuW,HuangX,XiongJ,WeiX*.InteractionofARandiNOSinlensepithelialcell:Anewpathogenesisandpotentialtherapeutictargetsofdiabeticcataract.ArchivesofBiochemistryandBiophysics.2017DOI:10.1016/j.abb.2017.01.007.
[2]WuJ,LiX,WanW,YangQ,MaW,ChenD,HuJ,ChenC,WeiX*.GigantolfromDendrobiumchrysotoxumLindl.bindsandinhibitsaldosereductasegenetoexertitsanti-cataractactivity:aninvitromechanisticstudy.JournalofEthnopharmacology.2017DOI:10.1016/j.jep.2017.01.026.
[3]LiL#,WeiX#£¨¹²1£©,WuB,XiaoY,YinM*andYangQ*.SiRNA-mediatedknockdownofId-1disruptscancerstemcell-likepropertiesandchemotherapyresistanceaccompaniedbyNanoginhibitioninGastricCancercells.OncologyLetters£¬2017,3,75-85.
[4]WuJ,LiX,FangH,YiY,ChenD,LongY,GaoX,WeiX*,ChenCY.Investigationofsynergisticmechanismandidentificationofinteractionsiteofaldosereductasewiththecombinationofgigantolandsyringicacidforpreventionofdiabeticcataract.BMCComplementAlternMed.201616(1):286.doi:10.1186/s12906-016-1251-5.
[5]FangH,HuX,WangM,WanW,YangQ,SunX,GuQ,GaoX,WangZ,GuL,ChenCY,WeiX*.Anti-osmoticandantioxidantactivitiesofgigantolfromDendrobiumaurantiacumvar.denneanumagainstcataractogenesisingalactosemicrats.JournalofEthnopharmacology.**:238-246.
[6]WuJ,LuC,LiX,FangH*,WanW,YnagQ,SunX,WangM,HuX,ChenC,WeiX*.Synthesisandbiologicalevaluationofnovelgigantolderivativesaspotentialagentsinpreventionofdiabeticcataract.PLoSOne.2015doi:10.1371/journal.pone.**.
[7]WeiX*,ChenD,YiY,QiH,GaoX,FangH,GuQ,WangL,GuL.Syringicacidextractedfromherbadendrobiipreventsdiabeticcataractpathogenesisbyinhibitingaldosereductaseactivity.EvidBasedComplementAlternatMed.2012doi.10.1155/2012/426537.
[8]FanW,Xu,F,Dong,FLi,X,Wei,X,Zhou,J,HuJ*.DendrowardolsAandB,TwoNewSesquiter-penoidsfromDendrobiumwardianumWarner.TetrahedronLetter,201354:1928-1930.
[9]Ò×ÑàȺ,ÑîÇɺ죬ËÕ¿¡·¼,³Â½¡,ÆÝ»Ô,³Âµ¤,κСÓÂ*.¿¹ÌÇÐÔ°×ÄÚÕϺòÑ¡?ÀàÐÂҩʯõúµÎÑÛÒºÁÙ´²Ç°ÖÊÁ¿¿ØÖÆ¡¢¼±¶¾¼°´Ì¼¤ÐÔÑо¿.ÖйúÖÐÒ©ÔÓÖ¾.201338(7):1061-1066.
[10]ÆÝ»Ô,³Â½¡,Ò×ÑàȺ,³Âµ¤,Íõ½£,À½Ü,Ò¶µ­Áá,Âí¶¬Éú,ÒüÁÖÃô,Ò¶Ïþϼ,κСÓÂ*.²»Í¬²úµØÌúƤʯõúÐÎ̬¼°ÓÐЧ²¿Î»³É·Öº¬Á¿±È½Ï.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨,2013£»30£¨4£©£º558-605.
[11]µóºìÐÇ,Ò×ÑàȺ,ÆÝ»Ô,¸ßÐÀÐÀ,·½»¨,κСÓÂ*,¹ËÇí,ÍõÁë,Íõá¿ÌÎ,¹ÅÁ·È¨.ʯõú·ÓÓ붡ÏãËáÁªºÏ¿¹°×ÄÚÕÏ×÷Óü°Æä»úÖÆÑо¿.ÖйúÖÐÒ©ÔÓÖ¾,2012£»37£¨16£©£º2429-2434.
[12]·½»¨,ÆÝ»Ô,¸ßÐÀÐÀ,ÍõÁë,Ò×ÑÞȺ,κСÓÂ*,¹ËÇí,Íõá¿ÌÎ,¹ÅÁ·È¨.ʯõú·ÓÓ붡ÏãËáÁªÓöÔÈ©ÌÇ»¹Ô­Ã¸µÄÒÖÖÆ×÷Óü°»úÖÆÑо¿.ÖÐÒ©ÐÂÒ©ÓëÁÙ´²Ò©Àí,2012£»23£¨1£©£º1-4.
[13]κСÓÂ*,¸ßÐÀÐÀ,¹ËÇí,ÍõÁë,Íõá¿ÌÎ.ʯõú·Ó¶ÔÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏøµÄÒÖÖÆ»îÐÔ¼°Æä»úÖÆÑо¿.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨,2011£»28£¨4£©£º393-395.
[14]κСÓÂ*,¸ßÐÀÐÀ,¹ËÇí,ÍõÁë,·½»¨,ÆÝ»Ô,Ò×ÑÞȺ,Íõá¿ÌÎ,¹ÅÁ·È¨.ʯõú·Ó¶ÔÈ©ÌÇ»¹Ô­Ã¸µÄÒÖÖÆ×÷Óü°Æä»úÖÆÑо¿.ÖÐÒ©ÐÂÒ©ÓëÁÙ´²Ò©Àí,2011£»22£¨1£©:1-3.
[15]ФæÃ,κСÓÂ*,¸ßÐÀÐÀ,¹ËÇí,ÍõÁë,·½»¨,¹ÅÁ·È¨,ÆÝ»Ô,Ò×ÑÞȺ.ʯõú·ÓÓ붡ÏãËáµÄADMET·Ö×ÓÄ£ÄâÔ¤²â.Î÷±±Ò©Ñ§ÔÓÖ¾£¬2011£»26£¨3£©£º211-213.
[16]Ò×ÑàȺ,ÆÝ»Ô,κСÓÂ*.ÑÛ²¿¸øҩмÁÐ͵ÄÑо¿.ÖйúÖÐÒ½ÑÛ¿ÆÔÓÖ¾,2011.21£¨4£©:237-239.
[17]κСÓÂ*,Âíΰ·ï,·½»¨,Î⿪Á¦,ÍõËÉ,¸ßÐÀÐÀ.²»Í¬¼«ÐÔʯõúÉúÎï¼îµÄÌáÈ¡·ÖÀë¼°¶ÔÈ˾§×´ÌåÉÏƤϸ°ûÔöÖ³µÄÓ°Ïì.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨,2010£»27£¨4£©:362-365.
[18]κСÓÂ*,Âíΰ·ï,¸ßÐÀÐÀ,·½»¨.ʯõúÉúÎï¼îÌáÈ¡·ÖÀ빤ÒÕµÄÑо¿.ÏÖ´úÖÐÒ©Ñо¿Óëʵ¼ù£¬2010£»27£¨3£©£º58-59.
[19]κСÓÂ*,Âíΰ·ï,·½»¨,Î⿪Á¦,¸ßÐÀÐÀ.ʯõúÌáÈ¡µÄ¶¡ÏãËá¶ÔÑõ»¯Ìõ¼þÏÂÈËÀྦྷ״ÌåÉÏƤϸ°ûÔöÖ³µÄÓ°Ïì.»·ÇòÖÐÒ½Ò©£¬2010£»3£¨3£©£º187-189.
[20]κСÓÂ*£¬ÁúÑÞ.ʯõúÌáÈ¡ÎÌÇÐÔ°×ÄÚÕÏ×÷Óü°µ°°×ÖÊ×éѧЧӦµÄʵÑéÑо¿.ÌìÈ»²úÎïÑо¿Ó뿪·¢£¬2008£»20£¨4£©£º36-39.
[21]κСÓÂ*,ÁúÑÞ.ʯõúÌáÈ¡Îï¶ÔÌÇÐÔ°×ÄÚÕÏ´óÊóÓÕµ¼ÐÍÒ»Ñõ»¯µª»ùÒòµÄµ÷¿Ø.½âÆÊѧÑо¿£¬2008£»30£¨3£©£º177-180.
[22]κСÓÂ*,ÁúÑÞ.ʯõúÌáȡΰ×ÄÚÕÏʵÑéÑо¿.ÏÖ´úÖÐÒ©Ñо¿Óëʵ¼ù£¬2008£»22£¨2£©£º27-31.
[23]ÎâÃû²¨,ÁúÑÞ,κСÓÂ*.ÖÐÒ©·ÀÖÎÌÇÐÔ°×ÄÚÕϵÄ×÷ÓûúÖÆÑо¿½øÕ¹.ÑÛ¿ÆнøÕ¹,2008£»28(4):316-318.
[24]κСÓÂ*£¬ÁúÑÞ.½ðîÎʯõúÉúÎï¼î¿¹ÌÇÐÔ°×ÄÚÕÏ×÷Óü°µ°°×ÖÊ×éѧЧӦµÄʵÑéÑо¿,ÌìÈ»²úÎïÑо¿Ó뿪·¢.2008,20:617-621.
[25]κСÓÂ*.ÌúƤʯõúcDNA±í´ïÎÄ¿âµÄ¹¹½¨¼°·ÖÎö.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨,2006,23(1):62-64.
[26]κСÓÂ*£¬·½»¨.ÌúƤʯõúʯ²î¼õcDNAÎÄ¿â¹¹½¨.¹ãÖÝÖÐÒ½Ò©´óѧѧ±¨,2005£»22(4):320-323.
[27]κСÓÂ*,ÂÞ×ÆÁá,Àî²Êϼ.×é֯оƬÓë»ùÒòоƬÔÚÖ×ÁöÑо¿ÖеÄÓ¦ÓÃ.½âÆÊѧÑо¿£¬2004£»26(4):305-306.
[28]κСÓÂ.ÌúƤʯõúÔ­Çò¾¥ÒºÌåÐü¸¡ÅàÑøÑо¿.ÖйúÏÖ´úÓ¦ÓÃҩѧ£¬2005£»22£¨6£©:471-473.
[29]κСÓÂ*,ÕÅÃú.ÌúƤʯõúÓë½Ê¹ÉÀ¶Ô­ÉúÖÊÌåÔÓ½»ÈÚºÏÑо¿.ÖвÝÒ©£¬2004£»35£¨8£©£º811-814.
[30]κСÓÂ*,·½»¨,Àî½Ü·Ò.ÖÐÒ©¹¦ÄÜ»ùÒòÑо¿.ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾£¬2005£»25£¨2£©£º181-185.
[31]κСÓÂ*,·½»¨.ʯõúÊôÖ²ÎïÉúÎï¼îÑо¿½øÕ¹.ÖйúÒ©ÊÂ,2005£»19£¨7£©£º445-447.
[32]κСÓÂ*,·½»¨.ʯõúÊôÖ²Îï·Ö×ÓÉúÎïѧÑо¿.ÉϺ£ÖÐÒ½Ò©´óѧѧ±¨£¬2005£»19£¨1£©£º47-49.

½ÌÓý±³¾° :
1991Äê±ÏÒµÓÚºþÄÏ´óѧÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡£
1998Äê±ÏÒµÓÚÕã½­´óѧÉúÃü¿ÆѧѧԺ¡£